Treatment Strategy: Steroids and Transfusions
At a Glance
Treatment for Diamond-Blackfan anemia usually balances corticosteroids with regular red blood cell transfusions. Care teams also monitor for steroid complications and transfusion-related iron overload using liver and cardiac MRI, with chelation when needed.
Managing Diamond-Blackfan Anemia (DBA) involves balancing the need for healthy red blood cells with the long-term risks of the treatments used to provide them. Most children follow one of two main pathways: corticosteroids (steroids) or chronic transfusions [1][2].
Pathway 1: Corticosteroids
Steroids like prednisone or prednisolone are the primary medication for DBA. They work by signaling the bone marrow to produce more red blood cells [1].
- Timing: A steroid trial is usually deferred until a child is at least one year old [1]. This delay balances the likelihood of an age-related response against the toxicity of early steroid exposure, while the child is supported by transfusions [3].
- Dosing Limits: A steroid trial involves an initial “induction” phase, followed by careful assessment and tapering. According to the 2024 international consensus, the absolute maximum maintenance dose is now set at 0.3 mg/kg/day [4]. Many experts prefer to keep the dose even lower—below 0.1 mg/kg/day—to minimize long-term harm [5]. These are targets for your physician; families must never adjust doses themselves.
- DO NOT STOP SUDDENLY: Abruptly discontinuing steroids can cause a life-threatening adrenal crisis.
- Risks and Side Effects: Long-term steroid use is toxic to a growing body. Key concerns include:
- Growth Suppression: Treatment for longer than two years or doses above 0.1 mg/kg/day are strongly linked to short stature [5].
- Adrenal Insufficiency: Chronic steroid use can suppress the body’s ability to make its own stress hormones. In one cohort, about 32% of patients with DBA (mostly those with significant steroid exposure) developed this condition [6]. Emergency Plan: You must have a concrete sick-day plan. Illness, vomiting, injury, or surgery may require clinician-directed “stress dosing” of hydrocortisone. A medical alert ID is strongly recommended.
- Bone and Eye Health: Steroids can weaken bones and increase the risk of cataracts or high eye pressure (glaucoma).
Pathway 2: Chronic Transfusions
If a child is under age one, does not respond to steroids, or cannot tolerate steroid side effects, they will receive regular red blood cell transfusions [1].
- The Target: The goal is to keep the “pre-transfusion” hemoglobin (the level measured just before the next bag of blood) between 9 and 10 g/dL [4]. This ensures the child has enough energy for normal growth and activity.
- Safety and Matching: Transfusions often occur every 3 to 5 weeks. Ensure your center uses leukoreduced and extended antigen-matched blood to minimize alloimmunization (the body attacking foreign blood) and transfusion reactions [4]. You should have a clear “when to call” plan for symptoms of a transfusion reaction, such as a sudden fever or chills.
Managing Iron Overload
The most serious complication of chronic transfusions is iron overload. The body has no natural way to get rid of the iron contained in transfused blood, so it builds up in the liver, heart, and endocrine glands [7].
Why Ferritin Is Not Enough
Ferritin is a common blood test used to track iron, but in DBA, it can be misleading. It may stay low even when iron is building up in organs, or it may spike during a simple cold [7]. To truly protect your child’s organs, doctors must use specialized MRI scans:
- Liver MRI (LIC): Measures the exact concentration of iron in the liver [7].
- Cardiac T2 (T2-star) MRI*: A specific scan used to detect iron in the heart muscle [8]. This is critical because heart failure from iron overload is preventable if caught early.
(The timing and frequency of these scans are individualized based on age, iron burden, and local expertise.)
Iron Chelation Therapy
To remove excess iron, children must take medications called chelators that grab the iron and help the body excrete it. These medications require strict safety monitoring:
- Deferasirox (Exjade/Jadenu): A daily pill or liquid. It requires close monitoring of kidney and liver function via a metabolic panel and urinalysis [9][10].
- Deferoxamine (Desferal): An older drug given as a slow infusion under the skin, often overnight. It is very effective but logistically difficult, and carries auditory (hearing) and ocular (vision) risks.
- Deferiprone (Ferriprox): A liquid or pill. While effective at removing heart iron, it carries a severe risk of agranulocytosis (a dangerous drop in white blood cells). Warning: Any fever or signs of infection while taking deferiprone requires immediate urgent care and a blood count [11].
Choosing between steroids and transfusions is a major decision. Your care team will help you weigh the daily burden of transfusions against the long-term physical risks of steroids to find the best path for your child’s specific needs.
Common questions in this guide
When might my child with Diamond-Blackfan anemia start steroid treatment?
What should we know about blood transfusions for DBA?
Why are MRI scans needed when ferritin is being checked?
How is iron overload treated in children with DBA?
Can my child stop steroids suddenly?
What symptoms should prompt a call after a transfusion?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If we start a steroid trial, what is the exact plan for induction and tapering the dose to the 'maintenance' level?
- 2.What is my child's current pre-transfusion hemoglobin target, and are we using leukoreduced and extended antigen-matched blood?
- 3.Is my child's ferritin level reflecting their true iron burden, or do we need to schedule a liver MRI (LIC) and cardiac T2* MRI now based on our center's protocol?
- 4.Given the risk of adrenal insufficiency, what is our explicit emergency plan (stress dosing) if my child becomes ill while on steroids?
- 5.What specific monitoring (like kidney function, eye exams, or white blood cell counts) do you perform for the side effects of our current treatment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science.
Bhoopalan SV, Suryaprakash S, Sharma A, Wlodarski MW
Frontiers in oncology 2023; (13()):1236038 doi:10.3389/fonc.2023.1236038.
PMID: 37752993 - 2
Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment.
Li H, Lodish HF, Sieff CA
Hematology/oncology clinics of North America 2018; (32(4)):701-712 doi:10.1016/j.hoc.2018.04.005.
PMID: 30047421 - 3
Case Report: Clinical management of a severe DBA patient with a novel RPS19 mutation.
Zhou J, Zhong J, Zhao Y, et al.
Frontiers in pediatrics 2025; (13()):1590183 doi:10.3389/fped.2025.1590183.
PMID: 40492264 - 4
Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.
Wlodarski MW, Vlachos A, Farrar JE, et al.
The Lancet. Haematology 2024; (11(5)):e368-e382 doi:10.1016/S2352-3026(24)00063-2.
PMID: 38697731 - 5
Short Stature in Patients with Diamond-Blackfan Anemia: A Cross-Sectional Study.
Wan Y, Gong X, Cheng S, et al.
The Journal of pediatrics 2022; (240()):177-185 doi:10.1016/j.jpeds.2021.09.015.
PMID: 34543620 - 6
Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).
Lahoti A, Harris YT, Speiser PW, et al.
Pediatric blood & cancer 2016; (63(2)):306-12 doi:10.1002/pbc.25780.
PMID: 26496000 - 7
Transfusion burden in early childhood plays an important role in iron overload in Diamond-Blackfan anaemia.
de Wilde JRA, van Dooijeweert B, van Vuren AJ, et al.
EJHaem 2022; (3(4)):1300-1304 doi:10.1002/jha2.524.
PMID: 36467824 - 8
Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study.
Cancado R, Watman NP, Lobo C, et al.
Hematology (Amsterdam, Netherlands) 2018; (23(9)):676-682 doi:10.1080/10245332.2018.1461292.
PMID: 29663858 - 9
[Deferasirox and Complex Proximal Tubulopathy. Presentation of two clinical cases].
Niño Taravilla C, Cervera Bravo Á, Otaola Arca H, et al.
Andes pediatrica : revista Chilena de pediatria 2021; (92(4)):584-589 doi:10.32641/andespediatr.v92i4.3154.
PMID: 34652377 - 10
Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.
Papneja K, Bhatt MD, Kirby-Allen M, et al.
Pediatric blood & cancer 2016; (63(8)):1480-3 doi:10.1002/pbc.25995.
PMID: 27082377 - 11
Diamond-Blackfan anaemia with iron overload: A serious issue.
Quarello P, Ramenghi U, Fagioli F
British journal of haematology 2022; (199(2)):171-172 doi:10.1111/bjh.18393.
PMID: 35929529
This page is for informational purposes only and does not constitute medical advice. Your child's hematology team should set treatment doses, monitoring, transfusion targets, and emergency plans; never change or stop treatment without their guidance.
Get notified when new evidence is published on Diamond-Blackfan anemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.